Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC

BACKGROUND： Combined hepatectomy and radiofrequency ablation（RFA） provides an additional treatment for patients with Barcelona Clinic Liver Cancer（BCLC） stage B hepatocellular carcinoma（HCC） who are conventionally deemed unresectable. This study aimed to analyze the outcome of this combination thera...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatobiliary & pancreatic diseases international 2016-08, Vol.15 (4), p.378-385
Hauptverfasser:	Hou, Yi-Fu, Wei, Yong-Gang, Yang, Jia-Yin, Wen, Tian-Fu, Xu, Ming-Qing, Yan, Lu-Nan, Li, Bo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Barcelona Clinic Liver Cancer system Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Catheter Ablation - adverse effects Catheter Ablation - mortality Chemoembolization, Therapeutic - adverse effects Chemoembolization, Therapeutic - mortality Combined Modality Therapy Endocrinology & Metabolism Female Gastroenterology and Hepatology hepatectomy Hepatectomy - adverse effects Hepatectomy - mortality hepatocellular carcinoma Humans Kaplan-Meier Estimate Length of Stay Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - therapy Male Middle Aged Neoplasm Staging Proportional Hazards Models radiofrequency ablation Retrospective Studies Risk Factors Time Factors transarterial chemoembolization Treatment Outcome 切除术射频消融患者手术切除晚期生存时间联合治疗肝细胞癌
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!